To investigate whether epigenetic silencing is involved in suppressing BTG2 expression in proliferating cells, we measured BTG2 induction in the human breast cancer cell line MDA-MB-231, following infection with an arrayed lentiviral shRNA library containing shRNAs against 43 KMTs. The gene discussed is BTG2; the disease is breast carcinoma.